IBT
PEN icon

International Biotechnology Trust’s Penumbra PEN Stock Holding History

International Biotechnology Trust’s Portfolio PEN Stock Details PEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-14,000
Closed -$1.62M – 60
2018
Q1 		$1.62M Buy
+14,000
New +$1.45M 0.63% 35

Other funds holding PEN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

International Biotechnology Trust's PEN Position: Q2 2018 in Review

International Biotechnology Trust sold out of Penumbra (PEN) in Q2 2018, closing a stake of 14,000 shares — an estimated $1.62M sold.

International Biotechnology Trust first reported a position in PEN in Q1 2018 and held it in 1 quarter. The position peaked at $1.62M in Q1 2018. 202 funds tracked by Wall St. Rank hold PEN as of Q2 2018.

  • International Biotechnology Trust reported no remaining Penumbra position as of Q2 2018 after selling out during the quarter.
  • International Biotechnology Trust sold 14,000 Penumbra shares in Q2 2018, an estimated $1.62M.
  • International Biotechnology Trust first reported a position in Penumbra in Q1 2018 and held it in 1 quarter.
  • International Biotechnology Trust's Penumbra position peaked at $1.62M in Q1 2018.
  • 202 funds tracked by Wall St. Rank held Penumbra as of Q2 2018.

Based on International Biotechnology Trust's 13F filing for Q2 2018, filed 13 Aug 2018.